Colgate-Palmolive Q1FY26 Results: Share Price Declines After Disappointing Earnings

Colgate-Palmolive (India) Ltd. released its Q1 FY25 financial results on July 22, 2025, revealing a decline across all financial metrics. The company posted lower-than-expected numbers due to ongoing challenges in the operating environment, subdued demand, and increased competition.

Colgate Palmolive QFY26 Results

For the quarter ended June 30, 2025, Colgate-Palmolive reported revenue of ₹1,434 crore, registering a 4.2% year-on-year (YoY) drop. EBITDA declined 11% YoY to ₹453 crore, with the margin contracting by 240 basis points to 31.6%. In comparison, the gross margin also narrowed to 68.9% from 70.6% a year ago. The net profit decreased by 12% YoY to ₹321 crore, compared to the anticipated ₹353 crore.

Pressures from Market Conditions and Demand Weakness

The company attributed the performance decline to difficult operating conditions intertwined with weak urban demand and heightened competitive pressure. Despite these challenges, Colgate-Palmolive’s premium product segment showed resilience and moderate growth during the quarter, offering a silver lining in an otherwise underwhelming quarter.

Read More: Britannia Share Price in Focus as Inflation and Competition Weigh on Margins!

Colgate-Palmolive (India) Share Price Performance

On July 22, 2025, Colgate-Palmolive (India) share price opened at ₹2,396.50 on NSE, above the previous close of ₹2,392.00. During the day, it surged to ₹2,410.00 and dipped to ₹2,352.00. The stock is trading at ₹2,391.20 as of 2:18 PM. The stock has declined by 0.03%.

Over the past week, it has moved up by 0.45%, over the past month, it has declined by 1.39%, and over the past 3 months, it has declined by 9.09%.

Conclusion

Colgate-Palmolive’s Q1 FY25 results reflect significant operational stress, with declines across revenue, profit, and margin levels. While the premium product category performed relatively well. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.